Sponsor Pipeline

AVEO Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06064877 A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or… Metastatic Head-and-neck Squamous-cell Carcinoma Recruiting
Phase 1
NCT05865535 A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia Cachexia Recruiting
Disease Areas
Head & Neck Cancer (1)
Get alerts when AVEO Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free